Find Ammonium Tetrathiomolybdate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 15060-55-6, Tiomolibdate diammonium, Ammonium tetrathiomolybdate(vi), Molybdate(2-), tetrathioxo-, diammonium, (t-4)-, Ammonium thiomolybdate, Ammonium molybdenum sulfide
Molecular Formula
H10MoN2S4
Molecular Weight
262.3  g/mol
InChI Key
ZKKLPDLKUGTPME-UHFFFAOYSA-N
FDA UNII
4V6I63LW1E

Ammonium Tetrathiomolybdate
Tiomolibdate Diammonium is an ammonium salt with potential antiangiogenic and antitumor activities. Tetrathiomolybdate has been found to deplete systemic copper reserves through an unknown mechanism. This agent has been shown to inhibit the activities of cuproenzymes, including superoxide dismutase 1 (SOD1) and cytochrome c oxidase (COX), which may contribute to its antiangiogenic and antitumor effects.
1 2D Structure

Ammonium Tetrathiomolybdate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
diazanium;bis(sulfanylidene)molybdenum;sulfanide
2.1.2 InChI
InChI=1S/Mo.2H3N.2H2S.2S/h;2*1H3;2*1H2;;
2.1.3 InChI Key
ZKKLPDLKUGTPME-UHFFFAOYSA-N
2.1.4 Canonical SMILES
[NH4+].[NH4+].[SH-].[SH-].S=[Mo]=S
2.2 Other Identifiers
2.2.1 UNII
4V6I63LW1E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Atn-224

2. Tetrathiomolybdate

3. Tetrathiomolybdate Bis-choline Salt

4. Tetrathiomolybdate, Dipotassium Salt

5. Tetrathiomolybdate, Disodium Salt

6. Thiomolybdate

7. Ttm Cpd

2.3.2 Depositor-Supplied Synonyms

1. 15060-55-6

2. Tiomolibdate Diammonium

3. Ammonium Tetrathiomolybdate(vi)

4. Molybdate(2-), Tetrathioxo-, Diammonium, (t-4)-

5. Ammonium Thiomolybdate

6. Ammonium Molybdenum Sulfide

7. Coprexa

8. Tiomolibdate Diammonium [usan]

9. Mfcd00136013

10. Attm

11. Att-m

12. 4v6i63lw1e

13. Diammonium Tetrathiomolybdate

14. Nsc-286644

15. Nsc-714598

16. Ammonium Tetrathiomolybdate [mi]

17. Ammonium Tetrathiomolybdate [who-dd]

18. Diazanium;bis(sulfanylidene)molybdenum;sulfanide

19. Ammonium Molybdenum Sulfide ((nh4)2mos4)

20. J-008719

21. Q4747310

22. Molybdate(2-), Tetrathioxo-, Ammonium (1:2), (t-4)-

23. Ammonium Tetrathiomolybdate(vi), 99% (99.99%-mo) Puratrem

2.4 Create Date
2007-02-09
3 Chemical and Physical Properties
Molecular Weight 262.3 g/mol
Molecular Formula H10MoN2S4
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass263.878087 g/mol
Monoisotopic Mass263.878087 g/mol
Topological Polar Surface Area68.2 Ų
Heavy Atom Count7
Formal Charge0
Complexity19.1
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Angiogenesis Inhibitors

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)


Chelating Agents

Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty